Objective To assess prevalence and associated factors of adverse childhood experiences (ACEs) among patients with severe mood disorders (SMDs). Design An institution-based cross-sectional study.

Presentation will Cover Recent Corporate Milestones Including Acceleration of Manufacturing Readiness for Entolimod™ FREMONT, CA / ACCESS Newswire / January 20, 2026 /Tivic Health® Systems, Inc.

Yet today, Polkadot trades at less than $2. Like many of the market's smaller altcoins, it fizzled out as rising interest ...

VO2 max, the measure of how much oxygen the body consumes during exercise, has become a ubiquitous tool for professional ...

Rio Silver Inc. ("Rio Silver" or the "Company") (TSX-V: RYO | OTC: RYOOF) is commencing the regulatory process required to enable physical ...

Investors in Eli Lilly have received a significant boost following a challenging start to the 2026 trading year. The U.S. Food and Drug Administration (FDA) has granted a Breakthrough Therapy ...